Stay updated on Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page
- Check7 days agoChange DetectedCreighton University Medical Center in Omaha was removed from the study site list and the total number of locations decreased from 281 to 280. This change reflects updated site availability for the trial.SummaryDifference0.1%

- Check14 days agoChange DetectedRecruitment status updated to 'No longer looking for participants'. The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label, while removing the older 'Intervention / Treatment' label and the previous revision note 'Revision: v3.5.5' and adding 'Revision: v3.6.0'.SummaryDifference0.1%

- Check21 days agoChange DetectedNew participating sites were added (CommonSpirit Saint Anthony Hospital Cancer Center; Saint Joseph Medical Center Hematology and Oncology - Silverdale) and existing sites (Saint Anthony Hospital; Saint Michael Cancer Center) were removed. The study now includes a Sample Collection procedure and the documentation updated to Revision: v3.5.5 with dates 2026-06-01 and 2027-05-15.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new page revision. The update likely reflects minor edits or fixes to the page content.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page's revision tag updated from v3.5.2 to v3.5.3, indicating a newer version of the page content; this is a versioning update rather than a substantive change to the study details.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision history updated: added v3.5.2 with entries for 2026-04-09 and 2026-04-13, and removed entries for v3.5.0 dated 2026-04-07 and 2026-04-08.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.